Home > Financial Ratios > INDEGENE

INDEGENE
Core EBITDA Growth

    Back to All Ratios
INDEGENE is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDEGENE
Please provide your vote to see the results

INDEGENE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 28.1045.1719.7777.55202.82

What is the latest Core EBITDA Growth ratio of INDEGENE ?

The latest Core EBITDA Growth ratio of INDEGENE is 28.10 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202428.10
Mar202345.17
Mar202219.77
Mar202177.55
Mar2020202.82

How is Core EBITDA Growth of INDEGENE Trending?

Years Core EBITDA Growth % Change
Mar2024 28.1
-37.79
Mar2023 45.17
128.48
Mar2022 19.77
-74.51
Mar2021 77.55
-61.76
Mar2020 202.82 -

Other Financial Ratios of INDEGENE


Compare Core EBITDA Growth ratio of peers of INDEGENE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDEGENE ₹13,699.2 Cr 2.6% 12.9% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,900.0 Cr -1.3% 4.7% 3.3% Stock Analytics
DIVIS LABORATORIES ₹148,474.0 Cr 1.9% 1.5% 41.9% Stock Analytics
CIPLA ₹118,166.0 Cr 3.4% 0.1% -3.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹105,849.0 Cr -4.8% 1.9% 20.3% Stock Analytics
DR REDDYS LABORATORIES ₹92,553.6 Cr -0.1% -1% -11.3% Stock Analytics


INDEGENE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDEGENE

2.6%

12.9%

NA
SENSEX

-1.5%

1.1%

1.2%


You may also like the below Video Courses